Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
07:30am, Saturday, 15'th Feb 2025
Investors should never ignore valuations when picking stocks. The price a stock trades at can drastically impact your overall returns.
Top 5 growth stocks to watch in 2025 as market momentum builds
06:48am, Saturday, 15'th Feb 2025
While concerns about a potential US recession persist, growth stocks have continued to outperform value stocks in 2024. Investors remain optimistic that the Federal Reserve's expected interest rate cu
Calls of the Day: Live Nation, Eli Lilly, AT&T, Adobe and Astera Labs
01:39pm, Thursday, 13'th Feb 2025
The Investment Committee discuss the latest Calls of the Day.
LLY Rises More Than 4% in a Week: How to Play the Stock
08:51am, Thursday, 13'th Feb 2025
Though Eli Lilly stock looks quite expensive, we suggest investors hold on to it as it still has robust growth prospects.
Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
08:00am, Thursday, 13'th Feb 2025
Eli Lilly and Company NYSE: LLY is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the stock market and healthcare system. Shares have performed well in 2025, with
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
04:30am, Thursday, 13'th Feb 2025
After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (LLY 0.92%) announced its full results and reiterated its earlier 2025 forecast. The company has be
Kenai Therapeutics Establishes Research Facility at Lilly Gateway Labs
07:00am, Wednesday, 12'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacemen
My 3 Top Picks for Stocks That Could Double Over the Next 3 Years
10:14am, Monday, 10'th Feb 2025
Finding stocks with the potential to double in just three years is no easy feat, even in this bull market.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Monday, 10'th Feb 2025
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
These Stocks Missed on Earnings, But Will Rebound Next Quarter
08:35am, Monday, 10'th Feb 2025
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
2 Growth Stocks to Buy Hand Over Fist in February
09:10am, Sunday, 09'th Feb 2025
Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in other industries -- even in healthcare, a sector some investors might consider
23 Upcoming Dividend Increases, Including 2 Kings
10:18am, Friday, 07'th Feb 2025
Excited to announce dividend hikes for 23 companies, including dividend kings SJW Group and California Water Service Group, with 5% and 7.1% increases. Companies with consistent dividend growth indica
Buy, Sell, Or Hold LLY Stock At $870?
09:43am, Friday, 07'th Feb 2025
Eli Lilly (NYSE: LLY) fourth-quarter performance exceeded the street expectations, with the company delivering adjusted earnings of $5.32 per share versus the projected $4.95. Revenue came in at $13.5
More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Nearly 90% of patients who achieved endoscopic response at one y
Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left
10:12pm, Thursday, 06'th Feb 2025
Eli Lilly's momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America's health focus across obesity and be
